Hochschulschrift(en), die von Michalakis, Stylianos begutachtet wurde(n)

Zobel, Lena Isabelle (2022): Mechanistic studies on retinitis pigmentosa for gene therapy approaches. Dissertation, LMU München: Fakultät für Biologie

Li, Yanfen (2021): Characterization of two-pore channel 2 in neovascular age-related macular degeneration. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Pavlou, Marina (2021): Retina regeneration: new strategies to treat inherited retinal dystrophies. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Wagner, Johanna (2021): Development and preclinical evaluation of a novel AAV vector-based gene therapy to treat retinitis pigmentosa type 45. Dissertation, LMU München: Graduate School of Systemic Neurosciences (GSN)

Sun, Fanfan (2020): Pathophysiology of α-synuclein spreading along the nigrostriatal dopaminergic pathway and its age-dependency. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Scheel, Constanze (2020): Generation and characterization of mouse and cell culture models to elucidate the function of Tet3 in neurons. Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Splith, Victoria (2019): Genome editing and transcriptional activation using CRISPR-Cas9 technology: exploring and manipulating epigenetic mechanisms in neurons. Dissertation, LMU München: Graduate School of Systemic Neurosciences (GSN)

Geserich, Anna Sophie (2018): The Tet3 interactome: novel insights into epigenetic mechanisms in development and disease. Dissertation, LMU München: Graduate School of Systemic Neurosciences (GSN)

Zhu, Kaichuan (2018): β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibition impairs synaptic plasticity via seizure protein 6 (SZE6). Dissertation, LMU München: Fakultät für Chemie und Pharmazie

Ferreira Rodrigues, Eva Sofia (2016): The effect of BACE1 inhibition in the amyloid plaque-associated axonal dystrophies. Dissertation, LMU München: Fakultät für Chemie und Pharmazie